Apyx Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Apyx Medical stock has a consensus rating of "Strong Buy" and an average price target of $6.50. The average 1-year stock price forecast is 58.15% higher than the current stock price, while the lowest is $6.00 (+45.99%) and the highest is $8.00 (+94.65%).

Price Target: $6.50 (+58.15%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$6.50	$6.00	$8.00
Change	+45.99%	+58.15%	+45.99%	+94.65%

* Price targets were last updated on May 8, 2026.

Analyst Ratings

The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	4	4	3
Buy	1	1	1	1	1	1
Hold	1	1	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Buy Reiterates $6	Buy	Reiterates	$6	+45.99%	May 8, 2026
Kyle Bauser Roth MKM	Roth MKM	Buy Reiterates $6	Buy	Reiterates	$6	+45.99%	Apr 14, 2026
Sam Eiber BTIG	BTIG	Buy Upgrades $6	Buy	Upgrades	$6	+45.99%	Mar 11, 2026

Financial Forecast

Revenue This Year

59.56M

from 52.84M

12.72%

from 52.84M

Revenue Next Year

65.76M

from 59.56M

10.40%

from 59.56M

EPS This Year

-0.28

from -0.27

EPS Next Year

-0.26

from -0.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	48.52M	44.51M	52.35M	48.10M	52.84M	59.56M
Revenue Growth	75.08%	-8.26%	17.61%	-8.11%	9.86%	12.72%
Gross Profit	33.60M	29.13M	33.76M	29.36M	33.04M	37.11M
Gross Margin	69.26%	65.45%	64.49%	61.04%	62.53%	62.30%
Operating Income	-14.45M	-23.31M	-19.95M	-18.85M	-6.45M	-6.87M
Net Income	-15.17M	-23.18M	-18.71M	-23.46M	-11.21M	-11.69M
EPS	-	-	-	-	-0.27	-0.28
Free Cash Flow	-5.33M	-5.54M	-1.90M	-11.58M	-7.11M	-10.20M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	59.9M
Avg	59.6M
Low	59.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	13.4%
Avg	12.7%
Low	12.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.28
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-